145 related articles for article (PubMed ID: 26514450)
1. Caveolin-1 in Breast Cancer: Single Molecule Regulation of Multiple Key Signaling Pathways.
Anwar SL; Wahyono A; Aryandono T; Haryono SJ
Asian Pac J Cancer Prev; 2015; 16(16):6803-12. PubMed ID: 26514450
[TBL] [Abstract][Full Text] [Related]
2. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers.
Witkiewicz AK; Dasgupta A; Sammons S; Er O; Potoczek MB; Guiles F; Sotgia F; Brody JR; Mitchell EP; Lisanti MP
Cancer Biol Ther; 2010 Jul; 10(2):135-43. PubMed ID: 20431349
[TBL] [Abstract][Full Text] [Related]
3. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors.
Martinez-Outschoorn UE; Pavlides S; Whitaker-Menezes D; Daumer KM; Milliman JN; Chiavarina B; Migneco G; Witkiewicz AK; Martinez-Cantarin MP; Flomenberg N; Howell A; Pestell RG; Lisanti MP; Sotgia F
Cell Cycle; 2010 Jun; 9(12):2423-33. PubMed ID: 20562526
[TBL] [Abstract][Full Text] [Related]
4. Expression of Stromal Caveolin- 1 May Be a Predictor for Aggressive Behaviour of Breast Cancer.
Eliyatkin N; Aktas S; Diniz G; Ozgur HH; Ekin ZY; Kupelioglu A
Pathol Oncol Res; 2018 Jan; 24(1):59-65. PubMed ID: 28236153
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of caveolin in breast cancer: a meta-analysis.
Ma X; Liu L; Nie W; Li Y; Zhang B; Zhang J; Zhou R
Breast; 2013 Aug; 22(4):462-9. PubMed ID: 23639584
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
Glait C; Tencer L; Ravid D; Sarfstein R; Liscovitch M; Werner H
Exp Cell Res; 2006 Nov; 312(19):3899-908. PubMed ID: 17014845
[TBL] [Abstract][Full Text] [Related]
8. Caveolin involvement and modulation in breast cancer.
Aoki MN; Amarante MK; Oda JM; Watanabe MA
Mini Rev Med Chem; 2011 Nov; 11(13):1143-52. PubMed ID: 22353223
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Gli-1 And Caveolin-1 Expression in the Human Small Cell Lung Cancer.
Wu J; Di D; Zhao C; Pan Q; Liu Y; Zhang X; Zhao X; Chen H
Asian Pac J Cancer Prev; 2018 Feb; 19(2):401-406. PubMed ID: 29479989
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 and breast cancer: a new clinical perspective.
Mercier I; Lisanti MP
Adv Exp Med Biol; 2012; 729():83-94. PubMed ID: 22411315
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.
Bonuccelli G; Casimiro MC; Sotgia F; Wang C; Liu M; Katiyar S; Zhou J; Dew E; Capozza F; Daumer KM; Minetti C; Milliman JN; Alpy F; Rio MC; Tomasetto C; Mercier I; Flomenberg N; Frank PG; Pestell RG; Lisanti MP
Am J Pathol; 2009 May; 174(5):1650-62. PubMed ID: 19395651
[TBL] [Abstract][Full Text] [Related]
12. Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival.
Wu KN; Queenan M; Brody JR; Potoczek M; Sotgia F; Lisanti MP; Witkiewicz AK
Cell Cycle; 2011 Dec; 10(24):4250-5. PubMed ID: 22134245
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Cancer Cell Growth and Progression by Caveolin-1 in the Tumor Microenvironment.
Yoon HJ; Surh YJ
Adv Exp Med Biol; 2020; 1277():63-74. PubMed ID: 33119865
[TBL] [Abstract][Full Text] [Related]
14. The role of caveolin-1 in tumors of the brain - functional and clinical implications.
Eser Ocak P; Ocak U; Tang J; Zhang JH
Cell Oncol (Dordr); 2019 Aug; 42(4):423-447. PubMed ID: 30993541
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP
Am J Pathol; 2002 Oct; 161(4):1357-69. PubMed ID: 12368209
[TBL] [Abstract][Full Text] [Related]
16. COX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breast.
Perrone G; Zagami M; Altomare V; Battista C; Morini S; Rabitti C
Virchows Arch; 2007 Dec; 451(6):1039-45. PubMed ID: 17851687
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers.
Sotgia F; Rui H; Bonuccelli G; Mercier I; Pestell RG; Lisanti MP
Cancer Res; 2006 Nov; 66(22):10647-51. PubMed ID: 17108100
[TBL] [Abstract][Full Text] [Related]
18. [Caveolin-1: oxidative stress target in tumor cells].
Wang WH; Li HY; Qu C; Zhang YJ; Zou W
Sheng Li Xue Bao; 2019 Oct; 71(5):792-798. PubMed ID: 31646333
[TBL] [Abstract][Full Text] [Related]
19. Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts.
Simpkins SA; Hanby AM; Holliday DL; Speirs V
J Pathol; 2012 Aug; 227(4):490-8. PubMed ID: 22488553
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 Dependent Endocytosis Enhances the Chemosensitivity of HER-2 Positive Breast Cancer Cells to Trastuzumab Emtansine (T-DM1).
Chung YC; Kuo JF; Wei WC; Chang KJ; Chao WT
PLoS One; 2015; 10(7):e0133072. PubMed ID: 26172389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
